Stellar Biotechnologies Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Latest Deal Type
-
Debt - PPP
- Financing Rounds
-
9
- Investments
-
3
Stellar Biotechnologies General Information
Description
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Contact Information
Website
www.stellarklh.comCorporate Office
- 332 East Scott Street
- Port Hueneme, CA 93041
- United States
Corporate Office
- 332 East Scott Street
- Port Hueneme, CA 93041
- United States
Stellar Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Stellar Biotechnologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Stellar Biotechnologies Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Stellar Biotechnologies Investments & Acquisitions (3)
Stellar Biotechnologies’s most recent deal was a Reverse Merger with Edesa Biotech. The deal was made on 07-Jun-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Edesa Biotech | 07-Jun-2019 | Reverse Merger | Drug Discovery | ||
| Neostell | 19-Jul-2016 | Joint Venture | Pharmaceuticals | ||
| CAG Capital | 07-Apr-2010 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Stellar Biotechnologies Exits (1)
Stellar Biotechnologies’s most recent exit was on 07-Jun-2019 from Edesa Biotech. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Edesa Biotech | 07-Jun-2019 | Completed |
|
Stellar Biotechnologies FAQs
-
When was Stellar Biotechnologies founded?
Stellar Biotechnologies was founded in 1999.
-
Where is Stellar Biotechnologies headquartered?
Stellar Biotechnologies is headquartered in Port Hueneme, CA.
-
What industry is Stellar Biotechnologies in?
Stellar Biotechnologies’s primary industry is Biotechnology.
-
Is Stellar Biotechnologies a private or public company?
Stellar Biotechnologies is a Private company.
-
What is Stellar Biotechnologies’s current revenue?
The current revenue for Stellar Biotechnologies is .
-
How much funding has Stellar Biotechnologies raised over time?
Stellar Biotechnologies has raised $25.5M.
-
Who are Stellar Biotechnologies’s investors?
Amaran Biotechnology and CAG Capital have invested in Stellar Biotechnologies.
-
When was Stellar Biotechnologies acquired?
Stellar Biotechnologies was acquired on 14-Apr-2020.
-
Who acquired Stellar Biotechnologies?
Stellar Biotechnologies was acquired by Edesa Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
